Role of EPHA2 receptor tyrosine kinase in ischemic stroke outcome

被引：0
|
作者：
Thundyil, J. [1 ]
Manzanero, S. [1 ]
Pavlovski, D. [1 ]
Coulthard, M. G. [2 ]
Arumugam, T., V [1 ]
机构：
[1] Univ Queensland, Sch Biomed Sci, St Lucia, Qld, Australia
[2] Univ Queensland, Sch Med, Acad Discipline Paediat & Child Hlth, Herston, Qld, Australia
来源：
INTERNATIONAL JOURNAL OF STROKE | 2012年 / 7卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：12 / 12
页数：1
相关论文
共 50 条
  • [21] Immunohistochemical observations of EPHA2 receptor tyrosine kinase in human pancreatic cancer.
    Hamaya, Yasushi
    Kataoka, Hideki
    Yamada, Masami
    Ikematsu, Yoshito
    Nishiwaki, Yoshiro
    Yasumi, Kazuhiko
    Ozawa, Takatika
    Nakamura, Ritsuko
    Sugimura, Haruhiko
    CANCER RESEARCH, 2006, 66 (08)
  • [22] Predictive value of the EphA2 receptor tyrosine kinase in lung cancer recurrence and survival
    Kinch, MS
    Moore, MB
    Harpole, DH
    CLINICAL CANCER RESEARCH, 2003, 9 (02) : 613 - 618
  • [23] Investigating electrostatic interactions between PIP2 and the EphA2 receptor tyrosine kinase
    Shi, Xiaojun
    Christie, Shaun
    Lingerak, Ryan
    Gilmore, Grant
    Rodriguez, Paloma
    Muller-Greven, Jeannine
    Buck, Matthias
    Wang, Bingcheng
    Smith, Adam
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 253
  • [24] Overexpression and functional alterations of the EphA2 tyrosine kinase in cancer
    Kinch, MS
    Carles-Kinch, K
    CLINICAL & EXPERIMENTAL METASTASIS, 2003, 20 (01) : 59 - 68
  • [25] Overexpression and functional alterations of the EphA2 tyrosine kinase in cancer
    Michael S. Kinch
    Kelly Carles-Kinch
    Clinical & Experimental Metastasis, 2003, 20 : 59 - 68
  • [26] Mutations of the EPHA2 Receptor Tyrosine Kinase Gene Cause Autosomal Dominant Congenital Cataract
    Zhang, Tianxiao
    Hua, Rui
    Xiao, Wei
    Burdon, Kathryn P.
    Bhattacharya, Shomi S.
    Craig, Jamie E.
    Shang, Dandan
    Zhao, Xiuli
    Mackey, David A.
    Moore, Anthony T.
    Luo, Yang
    Zhang, Jinsong
    Zhang, Xue
    HUMAN MUTATION, 2009, 30 (05) : E603 - E610
  • [27] 4-Substituted quinazoline derivatives as novel EphA2 receptor tyrosine kinase inhibitors
    Lim, Chae Jo
    Oh, Kwang-Seok
    Du Ha, Jae
    Lee, Jeong Hyun
    Seo, Ho Won
    Chae, Chong Hack
    Kim, Dae-Ghon
    Lee, Mi-Jin
    Lee, Byung Ho
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2014, 24 (17) : 4080 - 4083
  • [28] Effects of dasatinib on EphA2 receptor tyrosine kinase activity and downstream signalling in pancreatic cancer
    Chang, Q.
    Jorgensen, C.
    Pawson, T.
    Hedley, D. W.
    BRITISH JOURNAL OF CANCER, 2008, 99 (07) : 1074 - 1082
  • [29] A Conditional Transmembrane Peptide Inhibits Cell Migration by Activation of the EphA2 Receptor Tyrosine Kinase
    Alves, Daiane S.
    Westerfield, Justin M.
    Shi, Xiaojun
    Nguyen, Vanessa P.
    Stefanski, Katherine M.
    Smith, Adam W.
    Barrera, Francisco N.
    BIOPHYSICAL JOURNAL, 2019, 116 (03) : 176A - 176A
  • [30] Expression, purification, and initial characterization of the cytoplasmic domains of the human receptor tyrosine kinase, EphA2
    Zabell, KM
    Kinch, MS
    Knapp, DW
    Stauffacher, CV
    BIOPHYSICAL JOURNAL, 2004, 86 (01) : 254A - 254A
12345